LFB Biotechnologies S.A.S.U.

CIK 1377942 · Director by Deputization · last filed 2015-05-11

LFB Biotechnologies S.A.S.U. is a Director by Deputization who has filed 8 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for TGTX, was dated May 11, 2015. Across all open-market trades the lifetime net is +$10.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $417.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$417.75M

Companies

2

Total Filings

8

Lifetime Open-Market Net

$10.60M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
TGTX	10%+ Owner	7,614,855	$54.86	$417.75M	$750.0K	1	2015-05-11
GTC BIOTHERAPEUTICS INC (GTCB) Delisted	Director	21,299,906	—	—	$9.85M	6	2010-01-08

Recent Filings

8 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2015-05-11	TGTX	Mixed	+2,614,855	$752.5K	EDGAR
2010-06-17	—	Buy (P)	—	$0
2010-01-08	GTC BIOTHERAPEUTICS INC (GTCB) Delisted	Conv (C)	+5,299,071	$12.75M	EDGAR
2009-11-04	GTC BIOTHERAPEUTICS INC (GTCB) Delisted	Mixed	+13,985,995	$29.12M	EDGAR
2008-12-31	GTC BIOTHERAPEUTICS INC (GTCB) Delisted	Buy (P)	—	$0	EDGAR
2008-03-27	GTC BIOTHERAPEUTICS INC (GTCB) Delisted	Conv (C)	+14,500,000	$0	EDGAR
2008-02-25	GTC BIOTHERAPEUTICS INC (GTCB) Delisted	Buy (P)	+2,018,404	$1.76M	EDGAR
2007-01-05	GTC BIOTHERAPEUTICS INC (GTCB) Delisted	Buy (P)	+3,630,000	$4.46M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.